Health
UPDATE 2-Regeneron to stop enrolling very sick COVID-19 patients in antibody trial – Reuters
Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment…
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid
(Reuters) – Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment in hospitalized patients, based on the recommendation of an independent safety board.
The recommendation was based on a potential safety signal…
-
General21 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General18 hours agoRegional house price growth outstrips capital cities
-
General14 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General16 hours agoChina says Donald Trump’s Golden Dome plans risk weaponising space